The FDA has reaffirmed its commitment to the November 27, 2024, deadline for pharmaceutical partners to adhere to upcoming DSCSA regulations. With time running out, pharmaceutical stakeholders must assess their readiness and address any outstanding challenges.

Ensuring accurate and complete data exchange between trading partners is critical for DSCSA compliance. Yet many partners remain unprepared to meet these guidelines.

Helping You Become Compliant

Gateway Checker offers comprehensive solutions to address the challenges of DSCSA compliance. We specialize in helping you assess whether your pharmaceutical transactions comply with upcoming DSCSA regulations.

Are you prepared for the DSCSA deadline? See how Gateway Checker’s EPCIS and VRS Conformance Testing Platforms can give you and your supply chain partners the confidence that upcoming requirements are met.